ABR and pancreatic adenocarcinoma: Moreover, Notch, TGFβ and Shh ligands and their effectors could be interesting targets for high-throughput screening of drugs to be used in efficacious combined or sequential therapy of several malignant diseases such as MDB and pancreatic adenocarcinoma.